VF
ORIC icon

Virtu Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Virtu Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,372
Closed -$225K – 1736
2024
Q1 		$225K Buy
+16,372
New +$194K 0.02% 732
2023
Q4 		– Sell
-19,461
Closed -$118K – 1890
2023
Q3 		$118K Buy
19,461
+7,630
+64% +$62.5K 0.01% 794
2023
Q2 		$92K Sell
11,831
-7,793
-40% -$44.3K 0.01% 1055
2023
Q1 		$112K Buy
+19,624
New +$103K 0.01% 943
2022
Q2 		– Sell
-10,548
Closed -$56K – 1932
2022
Q1 		$56K Buy
+10,548
New +$95K ﹤0.01% 1102
2020
Q3 		– Sell
-6,167
Closed -$208K – 1378
2020
Q2 		$208K Buy
+6,167
New +$197K 0.02% 705

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial's ORIC Position: Q2 2024 in Review

Virtu Financial sold out of Oric Pharmaceuticals (ORIC) in Q2 2024, closing a stake of 16,372 shares — an estimated $225K sold.

Virtu Financial first reported a position in ORIC in Q2 2020 and held it in 6 quarters. The position peaked at $225K in Q1 2024. 113 funds tracked by Wall St. Rank hold ORIC as of Q2 2024.

  • Virtu Financial reported no remaining Oric Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 16,372 Oric Pharmaceuticals shares in Q2 2024, an estimated $225K.
  • Virtu Financial first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Virtu Financial's Oric Pharmaceuticals position peaked at $225K in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.